Skip to content

LifeMD, Inc. LFMD Gain (loss) on extinguishment of debt

Discontinued — last reported Q3 '25

Gain (loss) on extinguishment of debt at other companies

Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$3.51M

Segments

By segment

See full
Telehealth-$1.16M-255%

Other financials

Income statement

See full
Revenue$50.2M-1.4%
Gross profit$44.2M+3.5%
Operating income-$8.9M-656%
Net income-$8.9M-4,728%
EPS (diluted)-$0.20-900%

Balance sheet

See full
Cash & equivalents$34.5M+7.9%
Total debt$6.2M-76.9%
Total equity$15.0M+746%
Total assets$70.1M-4.7%

Cash flow

See full
Operating cash flow$444.6K-85.5%
CapEx$105.2K-10.5%
Free cash flow$339.4K-88.5%

Valuation

See full
Market cap$235.53M-61.7%
Enterprise value$207.22M-66.2%
P/E41.6×
P/S1.3×-2.3×

Profitability

See full
Gross margin86.1%+0.9pp
Operating margin-9.8%-0.9pp
Net margin3.1%+1.8pp
FCF margin10.4%+1.7pp

Returns & leverage

See full
Return on equity-393.6%
Debt / equity0.4×
Current ratio+0.2×

Where this comes from

Reported directly by LifeMD, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainsLossesOnExtinguishmentOfDebt.

The official record: LifeMD, Inc.’s 10-Q, filed November 17, 2025, on SEC EDGAR. View the filing →

Ask your AI about LifeMD, Inc.'s gain (loss) on extinguishment of debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeMD, Inc.'s gain (loss) on extinguishment of debt?
LifeMD, Inc. (LFMD) reported gain (loss) on extinguishment of debt of -$1.16M in Q3 2025.
What does gain (loss) on extinguishment of debt mean?
Gains or losses from retiring debt before maturity — gains when debt is repurchased below par, losses when premiums are paid for early redemption.